NCT01923974View on ClinicalTrials.gov

The Analgesic Effects of Melatonin

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
AnalgesiaAntihyperalgesia
Interventions
DRUG

Melatonin 10 mg

DRUG

Melatonin 100 mg

DRUG

Placebo

Trial Locations (1)

2200

Multidisciplinary Pain Center 7612, Neuroscience Center, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Lars Peter Holst Andersen

OTHER

NCT01923974 - The Analgesic Effects of Melatonin | Biotech Hunter | Biotech Hunter